Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

pembrolizumab 312 Carboplatin 159 Nivolumab 159 Cisplatin 141 Cyclophosphamide 135 Paclitaxel 129 Magnetic Resonance Spectroscopy 99 Specimen Handling 96 Radiotherapy 94 Gemcitabine 88 Dexamethasone 86 Biopsy 81 Ipilimumab 81 Docetaxel 78 Doxorubicin 77 Rituximab 71 Etoposide 69 Radiation 62 durvalumab 62 Lenalidomide 61 atezolizumab 61 Pemetrexed 59 Prednisone 59 Taxes 58 Bevacizumab 55 fludarabine 54 olaparib 53 Vincristine 52 Cytarabine 51 Fluorouracil 48

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × darlin protein, Dictyostelium × 1 year × Clear all

NCT03180736 2025-12-19

EMN14

European Myeloma Network B.V.

Phase 3 Completed

304 enrolled 19 charts 1 FDA

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡